| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/26/2005 | US20050112642 Fibroblast growth factor receptors and methods for their use |
| 05/26/2005 | US20050112641 Protein mixture which confers antibiotic resistance |
| 05/26/2005 | US20050112640 Nucleotide sequence for coding polypeptides for diagnosis,and cancer therapy, nervous system disorders, muscular disorders |
| 05/26/2005 | US20050112633 Alternatively spliced isoforms of sodium channel, voltage gated, type VIII, alpha (SCN8A) |
| 05/26/2005 | US20050112618 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 05/26/2005 | US20050112612 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 05/26/2005 | US20050112611 Using nucleic acid |
| 05/26/2005 | US20050112603 Method for purification, modification and immobilization of recombinant protein |
| 05/26/2005 | US20050112596 APRIL-A novel protein with growth effect |
| 05/26/2005 | US20050112582 Antibodies for the alpha platelet-derived growth factor receptor |
| 05/26/2005 | US20050112581 Anticancer, antitumor agents; monitoring mutant oncogens; signal amplification |
| 05/26/2005 | US20050112576 Vectors containing promoters; contacting with lymphocytes; inducting antigen presenting cells transduced with vector; encoding marking gene; gene transfer vectors |
| 05/26/2005 | US20050112575 Nucleic acid sequence encoding polypeptides; triggering calcium oscillation in ooctyes ; determination fertility |
| 05/26/2005 | US20050112574 Isolated nucleic acid; angiogenesis inhibitor |
| 05/26/2005 | US20050112568 Dgks as modifiers of the p53 pathwha and methods of use |
| 05/26/2005 | US20050112567 Serological assay for Neospora caninum |
| 05/26/2005 | US20050112563 Sub-sequences of 2'-deoxy-erythro-pentofuranosyl nucleotides that activate RNase H enzyme; diagnostics; antisense therapeutics |
| 05/26/2005 | US20050112559 Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS) |
| 05/26/2005 | US20050112556 Drug screening; endogenous human retrovirus; protein or peptide expressed by said retrovirus |
| 05/26/2005 | US20050112554 An insertion/a deletion early-stage-specific molecular marker, a single nucleotide variation (SNV) early-stage-specific molecular marker; SARS-CoV (coronaviruses) strains obtained from the earliest infected patients in a SARS outbreak, uses of these data for diagnosis, drug/vaccine development |
| 05/26/2005 | US20050112553 Screening a compound for effectiveness in treating a viral infection, a cellular gene functionally encoding a gene product whose overexpression inhibits reproduction of the virus but does not prevent survival of the cell; detecting the level of the gene product produced |
| 05/26/2005 | US20050112552 Screening for novel proteins having a functional PDZ domain involves an iterative process by which a peptide recognition unit or PDZ ligand is generated by screening an expression library or a combinatorial peptide library for binders to a known PDZ domain; carbohydrate, oligonucleotide, small drug |
| 05/26/2005 | US20050112150 Promoting exfoliation; mixture of polypeptide and protease; skin disorders; antitumor agents |
| 05/26/2005 | US20050112143 Method of developing an immunogenic composition and HIV vaccine |
| 05/26/2005 | US20050112142 Methods and compositions for treatment and prevention of HSV-2 infections and conditions |
| 05/26/2005 | US20050112141 Compositions and methods for treatment of neoplastic disease |
| 05/26/2005 | US20050112140 Immunogenic composition and method of developing a vaccine based on portions of the HIV matrix protein |
| 05/26/2005 | US20050112139 Immunogenic composition and method of developing a vaccine based on factor H binding sites |
| 05/26/2005 | US20050112138 Glycosylation immunogens |
| 05/26/2005 | US20050112136 Human immunodeficiency virus vaccine |
| 05/26/2005 | US20050112134 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
| 05/26/2005 | US20050112133 Chimera molecule containing protein and merozonite surface protein; induce immunologyresponse against antigens |
| 05/26/2005 | US20050112121 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 05/26/2005 | US20050112118 Compositions and methods for treating inflammatory disorders |
| 05/26/2005 | US20050112117 Molecules and methods for inhibiting shedding of KIM-1 |
| 05/26/2005 | US20050112110 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators |
| 05/26/2005 | US20050112108 Controlling gene expression of tumor suppression gene; binding to transcription factor |
| 05/26/2005 | US20050112107 Prevent adhesion of teeth; using argine, glycine, aspartic acid tripeptides |
| 05/26/2005 | US20050112103 Genetic engineered vectors encoding human low density lipoproteins ; control sequencing, gene expressionin heptacytes; anticholesterol agents; antilipemic agents |
| 05/26/2005 | US20050112099 Nucleic acids encoding polypeptides; gene expression vectors; immunotherapy |
| 05/26/2005 | US20050112096 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) |
| 05/26/2005 | US20050112095 Internal ribosome entry sites for recombinant protein expression |
| 05/26/2005 | US20050112090 Enhanced apoptosisinduced by tumor necrosis factor; administering to cell a polypeptide that gene expresses antagonist to tumor necrosis factor; anticancer agents; autoimmune diseases |
| 05/26/2005 | US20050111299 Device for mixing and/or injecting cements |
| 05/26/2005 | CA2545709A1 Methods and compositions for the treatment of b cell lymphomas and other cancers |
| 05/26/2005 | CA2545458A1 Dry recombinant human alpha 1-antitrypsin formulation |
| 05/26/2005 | CA2545409A1 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 05/26/2005 | CA2545062A1 Selective inhibitors of nuclear factor-kb activation and uses thereof |
| 05/26/2005 | CA2545053A1 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 05/26/2005 | CA2544820A1 Bacterial expression of protease inhibitors and variants thereof |
| 05/26/2005 | CA2544816A1 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 05/26/2005 | CA2544688A1 Cellular membrane protein assay |
| 05/26/2005 | CA2544483A1 Soluble tcr fusion molecules and methods of use |
| 05/26/2005 | CA2544347A1 Motoneuronotrophic factor gene sequences |
| 05/26/2005 | CA2544308A1 Cytokine antagonist molecules |
| 05/26/2005 | CA2544253A1 Novel sequences encoding hepatitis c virus glycoproteins |
| 05/26/2005 | CA2544239A1 Methods for the production of apolipoproteins in transgenic plants |
| 05/26/2005 | CA2536645A1 Long-wavelength fps |
| 05/25/2005 | EP1533619A2 Specific markers for metabolic syndrome |
| 05/25/2005 | EP1533617A1 Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer |
| 05/25/2005 | EP1533380A2 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus |
| 05/25/2005 | EP1533379A1 G protein chimeras |
| 05/25/2005 | EP1533378A2 Tyrosine kinase substrate protein Tks7 |
| 05/25/2005 | EP1533375A1 Method of transferring mutation into target nucleic acid |
| 05/25/2005 | EP1533374A1 Novel peptides having camp producing activity |
| 05/25/2005 | EP1533373A1 Method of judging sensibility to imatinib |
| 05/25/2005 | EP1533370A1 Novel atypical pneumonia-causing virus |
| 05/25/2005 | EP1533368A1 Method of screening insulin resistance improving drug |
| 05/25/2005 | EP1533003A1 Composition for degrading aflatoxins and other toxic substances |
| 05/25/2005 | EP1532452A2 Heterologous stimulus-gated ion channels and methods of using same |
| 05/25/2005 | EP1532446A2 G-protein coupled receptor ligands and methods |
| 05/25/2005 | EP1532280A2 Endosymbiotic gammaproteobacterium identified in ecteinascidia turbinata |
| 05/25/2005 | EP1532277A2 Single nucleotide polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy |
| 05/25/2005 | EP1532262A2 Petide amidation process |
| 05/25/2005 | EP1532261A2 Methods and dna constructs for high yield production of polypeptides |
| 05/25/2005 | EP1532254A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 05/25/2005 | EP1532253A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 05/25/2005 | EP1532252A2 Nuclear fertility restorer genes and methods of use in plants |
| 05/25/2005 | EP1532251A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 05/25/2005 | EP1532250A1 Fcyriia transgenic animal model for autoimmune disease |
| 05/25/2005 | EP1532247A2 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 05/25/2005 | EP1532245A2 Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
| 05/25/2005 | EP1532239A2 Methods and compositions for targeting secretory lysosomes |
| 05/25/2005 | EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/25/2005 | EP1532178A2 Artificial transcription factors |
| 05/25/2005 | EP1532177A2 Immunomodulatory constructs and their uses |
| 05/25/2005 | EP1532172A2 Immunogenic composition comprising an il-13 element and t cell epitopes, and itstherapeutic use |
| 05/25/2005 | EP1532171A1 Protein tyrosine phosphatase inhibitors |
| 05/25/2005 | EP1532170A2 Beta-sheet breaking peptides |
| 05/25/2005 | EP1532169A1 Variants of the major allergen phl p 1 from timothy grass |
| 05/25/2005 | EP1532168A2 Method for refolding neisserial nspa protein |
| 05/25/2005 | EP1532167A2 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 05/25/2005 | EP1532166A2 PEPTIDEs |
| 05/25/2005 | EP1532165A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 05/25/2005 | EP1532163A2 Androgen receptor coregulators |
| 05/25/2005 | EP1532142A2 Polypeptide cleavage process |
| 05/25/2005 | EP1531907A1 Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 05/25/2005 | EP1531860A2 Peptides for chlamydophila pneumoniae vaccine and diagnosis |
| 05/25/2005 | EP1531859A1 Compositions and methods for transepithelial molecular transport |
| 05/25/2005 | EP1531858A2 Immunogenic composition comprising a fusion protein and a saponin adjuvant |